Abstract P4-05-04: MECP2 is a frequently amplified oncogene and potential therapeutic target in TNBC
Year: 2015
Type: conference-abstract
Source: Cancer Research
Institutions: Harvard University, Dana-Farber Cancer Institute
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1596488543
